US5089260A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of treating ischemic tissue
Assignee: Emory University
•
Filing: 1990-05-11
•
Granted: 1992-02-18
•
Expires: 2010-05-11
Abstract
Abstract In accordance with the present invention, a method is provided for treating tissue damaged by ischemia. More particularly, the present invention relates to a method for treating tissue damaged by ischemia comprising injecting certain ethylene oxide-propylene oxide condensation surface-active copolymers. The surface-active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O) b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 950 to 4000, preferably approximately 1200 to 3500, and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes approximately 50% to 90% by weight of the compound.
Inventors
- 👤 Robert L. Hunter
- 👤 Alexander Duncan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 15:04
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/74; A61K31/765; A01; A01N; A01N1/00; A01N1/10; A01N1/12; A01N1/122; A01N1/126; A61K38/00; A61K38/16; A61K38/164; A61K38/166; A61K38/43; A61K38/44; A61K38/446; A61K38/46; A61K38/48; A61K38/49
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
107 words
A method of treating tissue damaged by ischemia in an animal or human comprising the step of injecting into the animal or human with the tissue damaged by ischemia an effective amount of a solution of a surface-active copolymer with the following general formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 950 to 4000 and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes from approximately 50% to 90% by weight of the compound.
Claim 2
Independent Claim
107 words
A method of treating tissue damaged by ischemia in an animal or human comprising the step of injecting into the animal or human with the tissue damaged by ischemia an effective amount of a solution of a surface-active copolymer with the following general formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 950 to 4000 and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes from approximately 50% to 90% by weight of the compound.
Claim 3
Dependent Claim
75 words
The method of claim 1 wherein said surface-active copolymer has the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 1200 to 3500, and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes approximately 50% to 90% by weight of the compound.
Claim 4
Dependent Claim
49 words
The method of claim 1 wherein said surface-active copolymer has the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein the molecular weight of the hydrophobe (C 3 H 6 O) is approximately 1750 and the total molecular weight of the compound is approximately 8400.
Claim 5
Independent Claim
108 words
A method of treating tissue damaged by ischemia in an animal or human comprising the step of injecting intravenously into the animal or human with the tissue damaged by ischemia an effective amount of a solution of a surface-active copolymer with the following general formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 950 to 4000 and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes from approximately 50% to 90% by weight of the compound.
Claim 6
Independent Claim
108 words
A method of treating tissue damaged by ischemia in an animal or human comprising the step of injecting intravenously into the animal or human with the tissue damaged by ischemia an effective amount of a solution of a surface-active copolymer with the following general formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 950 to 4000 and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes from approximately 50% to 90% by weight of the compound.
Claim 7
Dependent Claim
75 words
The method of claim 4 wherein said surface-active copolymer has the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 1200 to 3500, and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes approximately 50% to 90% by weight of the compound.
Claim 8
Dependent Claim
49 words
The method of claim 4 wherein said surface-active copolymer has the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein the molecular weight of the hydrophobe (C 3 H 6 O) is approximately 1750 and the total molecular weight of the compound is approximately 8400.
Claim 9
Independent Claim
108 words
A method of treating tissue damaged by ischemia in an animal or human comprising the step of injecting intramuscularly into the animal or human with the tissue damaged by ischemia an effective amount of a solution of a surface-active copolymer with the following general formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 950 to 4000 and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes from approximately 50% to 90% by weight of the compound.
Claim 10
Independent Claim
108 words
A method of treating tissue damaged by ischemia in an animal or human comprising the step of injecting intramuscularly into the animal or human with the tissue damaged by ischemia an effective amount of a solution of a surface-active copolymer with the following general formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 950 to 4000 and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes from approximately 50% to 90% by weight of the compound.
Claim 11
Dependent Claim
75 words
The method of claim 7 wherein said surface-active copolymer has the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 1200 to 3500, and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes approximately 50% to 90% by weight of the compound.
Claim 12
Dependent Claim
49 words
The method of claim 7 wherein said surface-active copolymer has the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein the molecular weight of the hydrophobe (C 3 H 6 O) is approximately 1750 and the total molecular weight of the compound is approximately 8400.
References Cited (Backward Citations)
US2674619A
Cited
US2854378A
Cited
US3089818A
Cited
US3140232A
Cited
US3740421A
Cited
US3450502A
Cited
US3641240A
Cited
US3577522A
Cited
US3590125A
Cited
US3980772A
Cited
US3867521A
Cited
US3956259A
Cited
US4073886A
Cited
US4179337A
Cited
USRE29909F1
Cited
USRE29909E
Cited
JPS525094A
Cited
US4100271A
Cited
US4305922A
Cited
US4186253A
Cited
US4395393A
Cited
US4407790A
Cited
US4609546A
Cited
SU1183112A1
Cited
US4600652A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-02-17 | 1995-08-19 | 1996-02-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-02-17 | 1999-08-19 | 2000-02-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-02-17 | 2003-08-19 | 2004-02-18 | $7700.00 | Window Closed / Lapsed |